Tocilizumab for Treatment of Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients. Boonpheng B, De Castro ICC, Ng YH, Blosser C, et al. Clin Transplant 2023 Feb 14:e14936. doi: 10.1111/ctr.14936.

Read + Share

Amedeo Smart

Independent Medical Education

Boonpheng B, De Castro ICC, Ng YH, Blosser C, et al. Tocilizumab for Treatment of Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients. Clin Transplant 2023 Feb 14:e14936. doi: 10.1111/ctr.14936.
PMID: 36787372